Ginsavit, 24 capsules, Pharco

Descriere

<b>Ginsavit, 24 capsules, Pharco</b><b>Properties: Therapeutic indications:</b> - Prophylaxis and treatment of symptoms determined by qualitatively and quantitatively unbalanced nutrition. - States of exhaustion (for example caused by stress), fatigue, weakness, decreased ability to concentrate, as well as for increasing mental tone. - During the convalescence period and in the elderly. - Physical effort, alcohol abuse, smokers, gastrointestinal disorders. - Diseases that decrease the body's defense capacity. <b>Composition:</b> A soft capsule contains:<ul><li> Ginseng extract 40 mg</li><li> Vitamin A (palmitate) 4000 IU</li><li> Vitamin D3 (cholecalciferol) 400 IU</li><li> Vitamin E (DL-á-tocopherol acetate) 10 mg</li><li> Vitamin B1 (thiamine mononitrate) 2 mg</li><li> Vitamin B2 (riboflavin) 2 mg</li><li> Vitamin B6 (pyridoxine hydrochloride) 1 mg</li><li> Vitamin B12 (cyanocobalamin) 1 ig</li><li> Folic acid 400 ig</li><li> Calcium pantothenate 10 mg</li><li> Nicotinamide 15 mg</li><li> Vitamin C (ascorbic acid) 60 mg</li><li> Inositol 20 mg</li><li> Choline bitartrate 20 mg</li><li> Copper (from copper sulfate) 1 mg</li><li> Zinc (from zinc sulfate) 1 mg</li><li> Manganese (from manganese sulfate) 1 mg</li><li> Magnesium (from magnesium sulfate) 10 mg</li><li> Potassium (from potassium sulfate) 5 mg</li><li> Iron (from ferrous fumarate) 10 mg</li><li> Calcium (from calcium acid phosphate) 92 mg</li><li> Phosphorus (from calcium acid phosphate) 71 mg</li><li> Excipients: capsule content: soybean oil, beeswax, hydrogenated soybean oil (type I), hydrogenated soybean oil (type II), soybean lecithin 45%, ethyl vanillin; capsule: gelatin, anhydrisorb, 85% glycerol, sodium ethyl p-hydroxybenzoate, n-propyl sodium p-hydroxybenzoate, black iron oxide (E172).</li></ul> <b>Administration method:</b> The recommended dose is 1-2 capsules per day. <b>Contraindications:</b> - Hypersensitivity to any of the components of the medicine. - Hypervitaminosis A and D. - Renal insufficiency. - Treatment with retinoids. - GINSAVIT is not administered in case of hypercalcemia, hypercalciuria, hyperkalemia, hyperphosphatemia, Addison's disease, Wilson's disease and urolithiasis infections. - Like other drugs containing iron, GINSAVIT should not be administered to patients with hemochromatosis, hemosiderosis or hemolytic anemia. - For people with peanut and soy allergy (due to the soy content). <b>Interactions:</b> - The simultaneous administration of ginseng with products containing caffeine increases the probability of adverse reactions. - GINSENG can potentiate the action of central nervous system drugs. It accentuates the side effects of monoamine oxidase inhibitors such as headache, tremors and mania. - GINSENG has a slight antiplatelet effect and can potentiate the action of warfarin. - Pyridoxine can decrease the plasma concentration of levodopa and phenytoin. - Colchicine, para-aminosalicylic acid and the ingestion of ethyl alcohol for more than 2 weeks cause malabsorption of vitamin B12. - Mineral oils can decrease the gastrointestinal absorption of vitamins A and D. - Vitamin D can increase the risk of hypermagnesemia in dialysis patients who use antacids containing magnesium. - Cholestyramine can decrease the intestinal absorption of vitamin D. - Hypercalcemia induced by thiazides can be amplified by calcium supplementation. - Calcium salts decrease the bioavailability of atenolol, norfloxacin and tetracycline and may decrease the effects of verapamil. - The absorption of iron can be decreased by simultaneous administration with tetracyclines, antacids or cimetidine; absorption can be increased by the simultaneous administration of vitamin C in higher doses (200 mg). - Iron salts decrease the absorption of levodopa, methyldopa, penicillamine, quinolones and tetracycline, as well as the effectiveness of L-thyroxine. <b>Presentation:</b> 24 soft capsules